Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-017963
Filing Date
2022-04-04
Accepted
2022-04-04 19:01:10
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1505
  Complete submission text file 0001213900-22-017963.txt   3047
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address
Rozov Yadin (Reporting) CIK: 0001921268 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35813 | Film No.: 22804585